Fatal pulmonary embolism caused by streptokinase treatment of deep venous thrombosis of the leg? 1990

M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
Department of Medicine, Huddinge University Hospital, Sweden.

During the last 10 years, four of 150 (2.7%) patients with deep venous thrombosis (DVT) treated with streptokinase (SK) at our department have died of pulmonary embolism (PE). A retrospective study of 1393 DVT patients treated with heparin during the period 1973-1986 showed that five (0.36%) of these patients died of PE while still on heparin. In this paper we describe the four patients treated with SK who developed fatal PE. In our opinion this increase in mortality does not warrant the use of SK in routine treatment of DVT of the leg before a proper trial has been conducted to compare the frequencies of pulmonary embolism after both treatments.

UI MeSH Term Description Entries
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008297 Male Males
D011655 Pulmonary Embolism Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS. Pulmonary Thromboembolism,Thromboembolism, Pulmonary,Embolism, Pulmonary,Embolisms, Pulmonary,Pulmonary Embolisms,Pulmonary Thromboembolisms,Thromboembolisms, Pulmonary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
January 1978, Annales de l'anesthesiologie francaise,
M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
November 1978, Angiology,
M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
January 1987, Respiration; international review of thoracic diseases,
M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
August 1990, Deutsche medizinische Wochenschrift (1946),
M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
January 1972, Hawaii medical journal,
M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
March 2009, La Revue du praticien,
M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
October 2012, Annals of vascular surgery,
M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
December 2012, La Revue du praticien,
M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
November 2005, La Revue du praticien,
M Holmström, and G Bratt, and E Törnebohm, and A S Rhedin, and D Lockner
March 1996, Clinical obstetrics and gynecology,
Copied contents to your clipboard!